Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries 2023 NCS CME Symposium - DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes By: PRLog July 11, 2023 at 14:52 PM EDT This CME Symposium takes place during the 2023 Neurocritical Care Society Annual Meeting #NCS2023 on Thursday, August 17, 2023 from 12:15 PM - 1:15 PM MST at the Phoenix Convention Center, Phoenix, Arizona.HAZLET, N.J. - July 11, 2023 - PRLog -- In this CME Symposium, during the 2023 Neurocritical Care Society Annual Meeting #NCS2023, expert faculty will discuss how direct oral anticoagulants (DOACs) have become widely used for the prevention and treatment of venous thromboembolism, stroke prevention in atrial fibrillation, and management of patients with coronary artery disease or peripheral artery disease. Large clinical trials have demonstrated that DOACs are as effective and safer than warfarin and are now widely recommended by guidelines. Despite their superior safety, a small percentage of patients suffer intracranial hemorrhage, which is associated with 30-day mortality rates approaching 50%. Specific agents that reverse anticoagulation with factor Xa inhibition and with oral direct thrombin inhibition have demonstrated effectiveness in clinical trials and are now preferred therapies in guidelines and statements from the American Heart Association/American Stroke Association (endorsed by multiple societies including the Neurocritical Care Society) and the American College of Cardiology Expert Consensus Decision Pathway. There is a lack of clinician awareness of prudent initial interventions for intracranial hemorrhage, clinical profiles of reversal agents, and guideline recommendations for reversal of anticoagulants. Intracranial hemorrhage is a complex clinical event that has been shown to benefit from specially trained, multidisciplinary care; a multidisciplinary team is recommended in clinical practice guidelines to improve outcomes and reduce mortality. Therefore, in this program, Program Chair Dr. Joshua Goldstein and an expert multidisciplinary faculty (Dr. Casey May, Dr. Anne Alexandrov, and Dr. Ashkan Shoamanesh) will provide attendees with best practices for optimal management of intracranial hemorrhage.Click here for more informationCHAIRJoshua Goldstein, MD, PhDProfessor of Emergency MedicineHarvard Medical SchoolEndowed Chair in Emergency Medicine ResearchMassachusetts General HospitalBoston, MassachusettsFACULTYAnne Alexandrov, PhD, AGACNP-BC, ANVP-BC,NVRN-BC, ASC-BCProfessor of Nursing and NeurologyThe University of Tennessee Health Science CenterMemphis, TennesseeCasey May, PharmD, BCCCPClinical Associate ProfessorThe Ohio State University College of PharmacyColumbus, OhioAshkan Shoamanesh, MDAssociate Professor of MedicineMarta and Owen Boris Chair in Stroke Research and CareMcMaster UniversityHamilton, Ontario, CanadaThis educational activity is intended for clinicians managing patients experiencing intracranial hemorrhage.Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #NCS2023 #DOACs #VTE #anticoagulation #strokeContactVoxmedia***@voxmedia.usPhotos: (Click photo to enlarge) Read Full Story - 2023 NCS CME Symposium - DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes | More news from this sourcePress release distribution by PRLog Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
2023 NCS CME Symposium - DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes By: PRLog July 11, 2023 at 14:52 PM EDT This CME Symposium takes place during the 2023 Neurocritical Care Society Annual Meeting #NCS2023 on Thursday, August 17, 2023 from 12:15 PM - 1:15 PM MST at the Phoenix Convention Center, Phoenix, Arizona.HAZLET, N.J. - July 11, 2023 - PRLog -- In this CME Symposium, during the 2023 Neurocritical Care Society Annual Meeting #NCS2023, expert faculty will discuss how direct oral anticoagulants (DOACs) have become widely used for the prevention and treatment of venous thromboembolism, stroke prevention in atrial fibrillation, and management of patients with coronary artery disease or peripheral artery disease. Large clinical trials have demonstrated that DOACs are as effective and safer than warfarin and are now widely recommended by guidelines. Despite their superior safety, a small percentage of patients suffer intracranial hemorrhage, which is associated with 30-day mortality rates approaching 50%. Specific agents that reverse anticoagulation with factor Xa inhibition and with oral direct thrombin inhibition have demonstrated effectiveness in clinical trials and are now preferred therapies in guidelines and statements from the American Heart Association/American Stroke Association (endorsed by multiple societies including the Neurocritical Care Society) and the American College of Cardiology Expert Consensus Decision Pathway. There is a lack of clinician awareness of prudent initial interventions for intracranial hemorrhage, clinical profiles of reversal agents, and guideline recommendations for reversal of anticoagulants. Intracranial hemorrhage is a complex clinical event that has been shown to benefit from specially trained, multidisciplinary care; a multidisciplinary team is recommended in clinical practice guidelines to improve outcomes and reduce mortality. Therefore, in this program, Program Chair Dr. Joshua Goldstein and an expert multidisciplinary faculty (Dr. Casey May, Dr. Anne Alexandrov, and Dr. Ashkan Shoamanesh) will provide attendees with best practices for optimal management of intracranial hemorrhage.Click here for more informationCHAIRJoshua Goldstein, MD, PhDProfessor of Emergency MedicineHarvard Medical SchoolEndowed Chair in Emergency Medicine ResearchMassachusetts General HospitalBoston, MassachusettsFACULTYAnne Alexandrov, PhD, AGACNP-BC, ANVP-BC,NVRN-BC, ASC-BCProfessor of Nursing and NeurologyThe University of Tennessee Health Science CenterMemphis, TennesseeCasey May, PharmD, BCCCPClinical Associate ProfessorThe Ohio State University College of PharmacyColumbus, OhioAshkan Shoamanesh, MDAssociate Professor of MedicineMarta and Owen Boris Chair in Stroke Research and CareMcMaster UniversityHamilton, Ontario, CanadaThis educational activity is intended for clinicians managing patients experiencing intracranial hemorrhage.Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #NCS2023 #DOACs #VTE #anticoagulation #strokeContactVoxmedia***@voxmedia.usPhotos: (Click photo to enlarge) Read Full Story - 2023 NCS CME Symposium - DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes | More news from this sourcePress release distribution by PRLog